Structure Therapeutics Inc. develops oral small molecule medicines to replace expensive injectable biologics and peptides. Lead candidate GSBR-1290 shows modest weight loss results in clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback